← Open Payments lookup

PRABIR MULLICK: Open Payments

NPI 1285603126 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,755 in 75 payments from 10 companies in 2025. Trend: 2023 $1,467 · 2024 $1,494 · 2025 $1,755

Food & beverage: $1,755
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.9$359
Alkermes, Inc.17$326
E.R. Squibb & Sons, L.L.C.9$253
ABBVIE INC.13$250
Otsuka America Pharmaceutical, Inc.12$243
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$111
Janssen Pharmaceuticals, Inc4$99
Teva Pharmaceuticals USA, Inc.3$59
Lundbeck LLC2$35
Neurocrine BioSciences, Inc.1$21

Products named: FANAPT, COBENFY, REXULTI, VRAYLAR, ARISTADA, LYBALVI, CAPLYTA, INVEGA SUSTENNA.

Industry payments across PA — which companies pay providers there.